| Citation: |
PENG Qiliu, WEI Shangmou, ZHANG Lei, GAN Liying, XIE Zhen, CHEN Qiaopei, WEI Bangning, ZHANG Zhi. Expression and Clinical Significance of miRNA-152 in Hepatocellular Carcinoma[J]. Cancer Research on Prevention and Treatment, 2021, 48(8): 769-773. DOI: 10.3971/j.issn.1000-8578.2021.21.0296
|
To investigate the expression of microRNA-152 in hepatocellular carcinoma, and analyze the correlation of miR-152 expression with the clinicopathological characteristics of hepatocellular carcinoma(HCC) patients.
Real-time PCR was used to detect the expression of miR-152 in tissue specimens from HCC and the adjacent non-cancerous hepatic tissues collected from 56 patients who underwent surgical treatment for primary HCC. The association between the expression of miR-152 and the clinical pathological characteristics and prognosis of HCC patients was analyzed.
The relative expression of miR-152 in hepatocellular carcinoma and corresponding adjacent non-carcinoma tissues were 0.616±0.041 and 0.768±0.042 (P=0.011). The expression of miR-152 was significantly associated with TNM stages (P=0.042), tumor differentiation (P=0.035), metastasis (P=0.048) and venous invasion (P=0.042). There was no significant association between the miR-152 expression and gender, age, AFP level, tumor number or tumor grade. The OS (P=0.035) and PFS (P=0.012) in the low miR-152 expression group were obviously shorter than those in the high miR-152 expression group. Multivariate Cox regression analysis showed that the low expression of miR-152, tumor recurrence and pathological classification were significant independent prognostic factors for the prognosis of hepatocellular carcinoma patients.
The expression of miR-152 is decreased in hepatocellular carcinoma tissues, and the low expression of miR-152 is significantly associated with TNM stages, tumor differentiation, metastasis, venous invasion and the prognosis of HCC patients.
Competing interests: The authors declare that they have no competing interests.
| [1] |
Komoll RM, Hu Q, Olarewaju O, et al. MicroRNA-342-3p is a potent tumour suppressor in hepatocellular carcinoma[J]. J Hepatology, 2021, 74(1): 122-134. doi: 10.1016/j.jhep.2020.07.039
|
| [2] |
Wu J, Xie N, Xie K, et al. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer[J]. Carcinogenesis, 2013, 34(12): 2861-2869. doi: 10.1093/carcin/bgt229
|
| [3] |
李自慧, 叶甲舟, 陈洁, 等. 解剖性肝切除术对合并微血管侵犯的肝癌患者早期复发的影响[J]. 中华肝胆外科杂志, 2018, 24(1): 18-22. doi: 10.3760/cma.j.issn.1007-8118.2018.01.005
Li ZH, Ye JZ, Chen J, et al. The impact of anatomical resection for hepatocellular carcinoma with microvascular invasion on early tumor recurrence[J]. Zhonghua Gan Dan Wai Ke Za Zhi, 2018, 24(1): 18-22. doi: 10.3760/cma.j.issn.1007-8118.2018.01.005
|
| [4] |
Brennan GP, Henshall DC. MicroRNAs as regulators of brain function and targets for treatment of epilepsy[J]. Nat Rev Neurol, 2020, 16(9): 506-519. doi: 10.1038/s41582-020-0369-8
|
| [5] |
Wei L, Wang X, Lv L, et al. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma[J]. Mol Cancer, 2019, 18(1): 147. doi: 10.1186/s12943-019-1086-z
|
| [6] |
Yang C, Zheng X, Ye K, et al. miR-135a Inhibits the Invasion and Migration of Esophageal Cancer Stem Cells through the Hedgehog Signaling Pathway by Targeting Smo[J]. Mol Ther Nucleic Acids, 2020, 19: 841-852. doi: 10.1016/j.omtn.2019.10.037
|
| [7] |
Rezaei T, Amini M, Hashemi ZS, et al. microRNA-181 serves as a dual-role regulator in the development of human cancers[J]. Free Radic Biol Med, 2020, 152: 432-454. doi: 10.1016/j.freeradbiomed.2019.12.043
|
| [8] |
Weng J, Luo J, Cheng X, et al. Deletion of G protein-coupled receptor 48 leads to ocular anterior segment dysgenesis (ASD) through down-regulation of Pitx2[J]. Proc Natl Acad Sci USA, 2008, 105(16): 6081-6086. doi: 10.1073/pnas.0708257105
|
| [9] |
Shen K, Cao Z, Zhu R, et al. The dual functional role of MicroRNA-18a (miR-18a) in cancer development[J]. Clin Transl Med, 2019, 8(1): 32. doi: 10.1186/s40169-019-0250-9
|
| [10] |
Li B, Xie Z, Li B. miR-152 functions as a tumor suppressor in colorectal cancer by targeting PIK3R3[J]. Tumour Biol, 2016, 37(8): 10075-10084. doi: 10.1007/s13277-016-4888-2
|
| [11] |
Liu Y, Gao S, Du Q, et al. miR-146a and miR-152 in prostate cancer and clinicopathological parameters[J]. J BUON, 2019, 24(4): 1692-1699. http://www.researchgate.net/publication/336824331_miR-146a_and_miR-152_in_prostate_cancer_and_clinicopathological_parameters/download
|
| [12] |
Ghazanchaei A, Mansoori B, Mohammadi A, et al. Restoration of miR-152 expression suppresses cell proliferation, survival, and migration through inhibition of AKT-ERK pathway in colorectal cancer[J]. J Cell Physiol, 2018, 234(1): 769-776. http://www.ncbi.nlm.nih.gov/pubmed/30076720
|
| [13] |
Yang D, Zhang Q. miR-152 may function as an early diagnostic and prognostic biomarker in patients with cervical intraepithelial neoplasia and patients with cervical cancer[J]. Oncol Lett, 2019, 17(6): 5693-5698. http://www.ingentaconnect.com/content/sp/ol/2019/00000017/00000006/art00116
|
| [14] |
汪毅, 袁伟, 马肖, 等. miR-152在结直肠癌组织中的表达及其与预后的关系[J]. 中华肿瘤杂志, 2016, 38(10): 763-766. doi: 10.3760/cma.j.issn.0253-3766.2016.10.010
Wang Y, Yuan W, Ma X, et al. Expression of microRNA-152 in colorectal cancer and its relationship with prognosis[J]. Zhonghua Zhong Liu Za Zhi, 2016, 38(10): 763-766. doi: 10.3760/cma.j.issn.0253-3766.2016.10.010
|
| [15] |
张红森, 郭国营, 杨翠, 等. MiR-152在膀胱癌中的表达以及对ERBB3/AKT2信号通路的调节作用[J]. 中国肿瘤, 2019, 28(1): 55-62. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHLU201901009.htm
Zhang HS, Guo GY, Yang C, et al. Expression of MiR-152 in Bladder Cancer and Its Effect on ERBB3/Akt Signal Pathway[J]. Zhongguo Zhong Liu, 2019, 28(1): 55-62. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHLU201901009.htm
|
| [16] |
Wang F, Ying H, He B, et al. Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma[J]. Tumour Biol, 2016, 37(4): 4945-4953. doi: 10.1007/s13277-015-4340-z
|
| [17] |
Dang YW, Zeng J, He RQ, et al. Effects of miR-152 on cell growth inhibition, motility suppression and apoptosis induction in hepatocellular carcinoma cells[J]. Asian Pac J Cancer Prev, 2014, 15(12): 4969-4976. doi: 10.7314/APJCP.2014.15.12.4969
|
| [18] |
Yin T, Liu MM, Jin RT, et al. miR-152-3p Modulates hepatic carcinogenesis by targeting cyclin-dependent kinase 8[J]. Pathol Res Pract, 2019, 215(6): 152406. doi: 10.1016/j.prp.2019.03.034
|
Figures(2) / Tables(3)
This work is licensed under a Creative Commons Attribution 3.0 License.
Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: